Rhythm Pharmaceuticals's chart data is dated 2026-10-08. There is no active technical signal. There are 5 published signal records.
Rhythm Pharmaceuticals last closed at $89.64 (+1.35%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -29.9×. Its overall grade ranks 352 of 738 stocks in Healthcare.
About this company
Rhythm Pharmaceuticals last closed at $89.64 (+1.35%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 352/738
Valuation grade A-
Related stocks
- AmgenCompetitor
비만·희귀질환 치료제 개발 경쟁사
- Novo NordiskCompetitor
비만 치료제 시장의 핵심 경쟁사
- Eli LillyCompetitor
비만 치료제 분야의 가장 큰 경쟁사
ETFs holding this stock
Harbor Health Care ETF
Details →About Rhythm Pharmaceuticals
- What technical signals does Rhythm Pharmaceuticals (RYTM) have?
- Rhythm Pharmaceuticals current technical signals: no active technical signal.
- Is Rhythm Pharmaceuticals a cup-and-handle pattern?
- No. Rhythm Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Rhythm Pharmaceuticals?
- Market cap: $5.98B. Trailing 12 months PER: -29.9×. Latest quarter PBR: 28.30×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Rhythm Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.